Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
1
HQ
Hod Hasharon, Israel
Sector
Health Tech & Life Sciences
About
SoulMedX's solution enables the precise dosage personalization of oral drugs at patients' homes at the time of consumption, combining artificial intelligence, big data, and flexible dispensing technologies.
The AI-powered system enables a remote adjustment of dosage based on patient behavior.
Q&A
- What is the current status of SoulMedX?
- SoulMedX is currently inactive, having ceased operations in January 2025.
- What is SoulMedX's primary focus or one-liner?
- SoulMedX focuses on "Oral Drug Dosage Precision".
- When was SoulMedX founded?
- SoulMedX was founded in July 2018.
- What is SoulMedX's primary sector?
- SoulMedX's primary sector is Health Tech & Life Sciences.
- What technologies does SoulMedX utilize?
- SoulMedX utilizes Artificial Intelligence in its solutions.
- Who are the founders of SoulMedX?
- The founders of SoulMedX are Eran Katz (CEO) and Dr. Moshe Brand (CTO).
- What is SoulMedX's product stage?
- SoulMedX's product is in the R&D stage.
Team · 2
Founder · CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Engagement
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B2CB2C
Highlights
Verified
Tags
oral-drugsartificial-intelligencemedicationpatient-engagementbehavior-analyticsdigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/40670001 |
Identifiers & details
| Founded | 2018-7 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Jan 2025 ceased to operate |